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Acinetobacter Bacterium and Disease 
The Acinetobacter genus is home to a wide range of bacteria that are gram-negative, 
aerobic, non-motile, oxidase-negative, catalase positive, and coccobacilli with a G+C content of 
39 to 47% (Bergogne-Berezin, 1996).  These bacteria are universal as they reside in the soil, 
water, sewage, various surfaces; and are also able to infect humans; however, a majority of the 
infections are caused by the species Acinetobacter baumannii.  This bacterium is the most 
prevalent etiological cause of the Acinetobacter infections due to it being a nosocomial infection 
or one that is acquired in a health care setting (Bergogne-Berezin, 1996).  The infections that 
occur in a healthcare environment are typically isolated to intensive care units and other settings 
with very ill patients (Bergogne-Berezin, 1996). 
Challenges Associated with Treating Acinetobacter 
Acinetobacter baumannii is capable of causing several diseases within an infected 
patient.  These range from pneumonia to urinary tract infections.  The symptoms presented vary 
depending on the specific disease (Bergogne-Berezin, 1996).  Because Acinetobacter baumannii 
acts as a typical gram-negative, opportunistic pathogen, it infects areas such as the respiratory or 
urinary tracts.  It is common for patients with exposure to mechanical ventilators to suffer from 
infections by Acinetobacter baumannii (Bergogne-Berezin, 1996). 
These infections are difficult to treat as Acinetobacter baumannii exhibits multi-drug 
resistance and, as such, is hard to control (Maragakis, 2008).  These drugs include penicillins, 
cephalosporins, and carbapenems.  Polymyxins appear to be the most reliable drugs to use 
against Acinetobacter baumannii, but there are subtypes that exhibit resistance to this class of 
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drugs too (Maragakis, 2008).  The high rates of antibiotic resistance in Acinetobacter species and 
specifically in Acinetobacter baumannii make it difficult to treat (Bergogne-Berezin, 1996).   
Next, the bacteria are able to survive for a long amount of time on surfaces and in many varying 
environmental conditions.  Outbreaks of this bacterial species are common because it possesses 
these qualities (Maragakis, 2008).   
Acinetobacter baumannii is not the only bacterial species that is difficult to treat; many 
other pathogens known by the acronym ESKAPE (E. faecium, S. aureus, K. pneumoniae, A. 
baumannii, P. aeruginosa, and Enterobacter species) also have high rates of antibiotic resistance.  
These bacteria are pathogens that are commonly found in a healthcare setting and are resistant to 
a plethora of antibiotics (Hernandez, 2015).  With each being handled on a case-by-case basis, a 
method to determine the subtype of the bacteria, to determine its resistance, would be very 
useful.   
Phage Typing 
We have evidence that bacteriophages and their use would be valuable to the medical for 
the identification and possible therapy of drug resistant and multi-drug resistant (MDR) bacterial 
strains.  The healthcare community is seeing a rise in the number of MDR bacteria in primarily 
hospital settings.  These bacteria cause many problems for the healthcare providers and the 
patients.  MDR bacteria at the very least can extend hospital stays and thereby increasing all 
resources that go into that patient’s visit and at worst can cause death (de Kraker, 2011).  We 
believe that by using phages and phage techniques that these costs and deaths can be reduced. 
We hoped that through this work we would hope to contribute to the overall knowledge of phage 
and specifically to phage typing.  Furthermore, we believe that with phage typing the problems 
listed can be alleviated.  In phage typing, collections of bacteriophages are administered to the 
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bacteria isolate.  The pattern in which the known phages lyse and kill the bacteria reveal the 
subtype of that bacteria (Bouvet, 1989).  This information would be invaluable to the healthcare 
professionals, as it would allow them to choose antibiotics to which the bacteria are not resistant 
(Bouvet, 1989).  Bouvet et al. have also proved this method successful for Acinetobacter in the 
late 1980s.   
To accomplish phage typing, a set of known and characterized bacteriophages specific to 
that bacterial genus must be used.  The lack of bacteriophages known to infect bacterial species 
is one hurdle that must be overcome to make the technique viable.  A lack of up to date 
information categorized in databases presents another obstacle. (Baggesen, 2010). 
Phage Therapy 
Another phage technique that is being explored is phage therapy.  In this technique, 
bacteriophages are administered to a patient with a bacterial infection with the purpose of the 
bacteriophages infecting and killing the harmful bacteria in the patient.  As with all phages, they 
are specific to one species or subtype of a bacterial species (Baggesen, 2010).  Due to this 
requirement, further research into phage therapy requires known characterized phage.  Our 
project provides these known phages for both typing and therapy experimentation. 
Currently, research is being done with phage therapy to prove its efficacy.  Most 
interestingly, labs have demonstrated phage therapy’s ability to improve the use of antibiotics.  
Through the administration of phage, targeted bacteria are presented with evolutionary tradeoffs 
that, in this study, resulted in loss of antibiotic resistance for Pseudomonas aeruginosa (Chan, 
2016).  Phage research is a promising field that requires large amounts of information and sets of 





MATERIALS AND METHODS 
Acinetobacter Culturing 
Acinetobacter baylyi strains were obtained from previously existing cultures maintained 
by Rose-Hulman’s lab manager Shannon Tieken.  The existing cultures were t-streaked on 
MacConkey agar.  A single bacterial culture was picked from that plate using a flame sterilized 
loop and t-streaked onto a Luria Bertani (LB) Agar plate.  Furthermore, liquid cultures were 
created from the bacteria grown up on that LB plate.  The liquid cultures were stored in test tubes 
containing 5 mL of LB broth.  A single bacterial culture from the LB plate was removed using an 
autoclaved toothpick that was then placed into the LB broth and allowed to grow overnight at 
37ºC and shaking at 280 RPM (Mattila, 2015).   
Soil Collection & Isolation of Phage 
Phage was isolated from soil samples collected on Rose-Hulman’s campus.  Soil was 
taken from an empty patch of ground located behind the White Chapel.  Approximately, 1 gram 
of soil was collected and suspended in 6 mL of Luria-Bertani Broth.  300 µL of overnight grown 
A. baylyi culture was then added and the solution was incubated at 37ºC for 6 hours with shaking 
at 280 RPM.  After the 6 hours, drops of chloroform were added to lyse bacterial cells possibly 
containing phage and the solution was left to sit for 15 minutes.  Following that, the solution was 
subjected to vacuum filtration with 5.5cm 23 micron pore size Whatman Qualitative Filter Paper 
in order to remove soil and bacterial debris.  The filtrate was then taken and spun at 11,000g for 
5 minutes.  PEG6000 and NaCl were then added to the supernatant at final concentrations of 
10% and 1M respectively.  The solution was stored overnight at 4ºC and spun at 11,000g for 20 
minutes the next morning.  The supernatant was discarded and the surviving pellet was dissolved 
in PBS.  This dissolution was filtered with 0.2µm filters.  The filtrate was taken and serially 
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diluted 1:10.  Each dilution was taken and plated for plaques using a double plaque assay (Yang, 
2010; Stenholm 2008; Carey-Smith, 2006). 
Double Plaque Assays 
250 mL of top agar was created in addition to regular LB agar and broth in order to 
perform the assay.  Top agar was created from a 0.7% agar formulation of the LB agar recipe. 
Bacterial phage cultures were added to 2mL exponential phase Acinetobacter baylyi and 
incubated for 5 minutes.  After incubation, the phage and bacteria were added to 6 mL ~45ºC 
melted top agar and poured onto a dried LB agar plate.  The plates were allowed to cool and then 
checked after 4 hours for growth and 6 hours and overnight for plaque formation (Mocé-Llivina, 
2004).   
Purification of Phage 
Single plaques were purified following isolation.  To select one plaque a sterile Pasteur 
pipette was used and a plaque was punched from the agar and placed in SM buffer.  The solution 
was then shook in 37ºC at 280 RPM for 2 hours.  Chloroform was added to the solution at 50µL 
per 1 mL of SM buffer.  Phage was separated into organic layer and added to exponential phase 
A. baylyi culture.  This culture was then incubated for 20 minutes and used to re-perform a 
double plaque assay (Stenholm, 2008). 
One-Step Growth Curve 
The one-step growth curves used 0.7% LB top agar and 1.5% regular recipe agar.  
Exponential growth phase Acinetobacter baylyi was grown and incubated for two hours at 37ºC 
and 280RPM. 10 mL of the growth phase culture was infected at an MOI of 0.01 by a prepared 
culture of phage from the purification step.  The solution was left to adsorb for a total of 5 
minutes.  After the 5 minutes, the solution was centrifuged in order to remove any excess phage.  
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The supernatant was discarded and the pellets were re-suspended in 5 mL of LB broth and 
incubated at 37ºC.  Two sets of samples were collected every 5 minutes for 40 minutes.  Each set 
was immediately 10-fold serially diluted and plated for titration.  The second set was treated with 
chloroform to release intracellular phage.  This set was then used to determine the eclipse period 
of the page.  From the plaque forming units on the plates, the latent and burst size of the page 







Bacteriophage that infect Acinetobacter baylyi can be found in soil surrounding Rose-
Hulman Institute of Technology.  During Dr. O’Connor’s microbiology class, students were able 
to isolate Acinetobacter baylyi from soil around Rose-Hulman’s campus.  Bacteriophages are 
found in areas where the bacteria they infect are found, because of those factors, we 
hypothesized that bacteriophages infecting Acinetobacter baylyi could be found on Rose-
Hulman’s campus.  Soil samples were collected from unfertilized ground behind the White 
Chapel at the West end of campus.  Following our isolation protocol, phage was acquired via 
verification and culturing with double plaque assays. These assays were used throughout the rest 
of the experiment for purification and amplification and were able to show that phage from 
Acinetobacter baylyi can be found at Rose-Hulman (Figure 1). 
Following isolation, we were able to use that isolated phage existing in the assay for 
purification and amplification protocol.  It is likely that the phage plaques present in the assays 
obtained from isolation contained more than one strain of bacteriophage.  In order to obtain one 
specific strain it was necessary to perform successive rounds of plaque assays to pick and 
therefore isolate one plaque of bacteriophage.  This purification was carried out using lab 






The ESKAPE pathogens identified as targets for MDR research have been studied with 
varying amounts of attention.  Their threat to the future of patient care presents issues that should 
be studied along with alternatives to treatment (Hernandez, 2015).  We think that alternatives lie 
in the use of bacteriophages for both phage typing and phage therapy.  To adequately make use 
of those techniques large amounts of characterized phage must be understood and that 
information available.  Our project focuses on those rudimentary steps necessary for the use of 
those advanced techniques. 
Our project was successfully able to isolate bacteriophage from soil on Rose-Hulman’s 
campus and purify a single plaque with successive rounds of double plaque assays.  Due to a loss 
of those purified plates, characterization of the obtained plaques was not able to be accomplished 
in the given time frame of the experiment.  In order to fully complete the project, then several 
experiments would need to be completed after reobtaining sets of purified, unknown phage.   
Each of these experiments involve characterization of a set of phages that would need to be 
obtained.  The primary characterization technique employed would be restriction fragment length 
polymorphism (RFLP).  RFLP would give us both the knowledge that our obtained set of phages 
are indeed different as well as a profile of those phages.  Further DNA work would also be 
needed (Merabishvili, 2014).  Upon verification of separate phages, DNA or RNA would need to 
be isolated and sent for sequencing to complete the main characterization of our phages.   
Additional characterization experiments would also be needed, as phages are often 
classified on several different criteria.  Plaque size and type are two different physical 
characteristics of the phages that are commonly used (Ackermann, 2010).  Plaque size would be 
measured by simply taking the diameter of the acquired plaques, and plaque type of lytic or 
9 
 
lysogenic can be recorded through simple observation of the plaques themselves (Urban-Chmiel, 
2015; Merabishvili, 2014).  Lastly, activity of the phages would be characterized using a one-
step growth curve.  That assay would quantify the infective activity of the phages with their host 
bacterium (Yang, 2010; Stenholm, 2008; Carey-Smith, 2006; Adams, 1959; Merabishvili, 2014). 
In the future, phages may have several applications ranging from typing to therapy.  With 
a database of characterized phage made available, then phage typing methods could be used in 
the future in order to identify the subtypes of bacterial strains and help physicians to choose 
treatment options based on those phage profiles.  Additionally, phage therapy has been gaining 
attention as a possible treatment option to use with antibiotic treatment.  Phage therapy has the 
added benefit of a historical basis for its use dating back to World War I and extensive use in 
former Soviet Bloc states (Levine, 1992).  Current research shows that phage therapy could be a 
viable treatment option to use with antibiotics to increase their effectiveness and further research 






 Our project focused on the discovery and identification of bacteriophage that infected 
Acinetobacter baylyi.  We succeeded in isolating and purifying those phages from soil samples 
taken on the campus of Rose-Hulman Institute of Technology.  Our project shows that phages 
infecting these bacteria may be found in the soil in which they inhabit and if their prevalence in 
the environment matches that Acinetobacter baylyi, then a great diversity of phage may be 
present.  Phage research has the potential for many applications including phage typing and 
therapy.  To make those applications viable, a great deal of collected and characterized phage 
need to be studied.  This project aimed to contribute to that collection.  It provides a base for 
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Figure 1: Double plaque assay containing initial purification.  Bacterial phage cultures were 
added to 2mL exponential phase Acinetobacter baylyi and incubated for 5 minutes.  These phage 
were taken from soil from around Rose-Hulman’s campus and isolated using vacuum filtration 
with 5.5cm 23 micron pore size Whatman Qualitative Filter Paper in order to remove soil and 
bacterial debris.  That filtrate was spun into a pellet.  These pellets were then dissolved in PBS 
and subjected to a 0.2 micron filter.  This phage solution was then serially diluted and incubated.  
After incubation, the phage and bacteria were added to 6 mL ~45ºC melted top agar and poured 
onto a dried LB agar plate.  The plates were allowed to cool and then checked after 4 hours for 
growth and 6 hours and overnight for plaque formation.  Plaque formation indicates the presence 
of phage that infects Acinetobacter baylyi from the isolation protocol. 
 
 
